Affiliation:
1. Universidade de São Paulo, Brazil
2. Universidade de São Paulo, Brazil; Instituto do Câncer do Estado de São Paulo, Brasil
Abstract
ABSTRACT Introduction: nose is the central point of the face and vulnerable to the occurence of non-melanoma skin cancer (NMSC), impacting on appearance. The paramedian forehead flap (PMFF) is considered the best option to treat extensive nasal defects. The objective of this study is to present the experience on PMFF for nasal reconstruction in the treatment of NMSC of a cancer referral center. Methods: retrospective study was carried out through data from medical records of patients who underwent nasal reconstruction with PMFF due to NMSC at the Cancer Institute of the State of São Paulo (ICESP). Results: 111 patients were identified, mostly ederly, with comorbidities and on initial tumors (T1 and T2). Basal cell carcinoma (BCC) was the predominant histological type. Dorsum and tip were the most affected subunitis. In addition to skin coverage, reconstruction of the lining and structural framework was also performed in half of the cases. Second intention healing was the technique of choice in closing the donor area. Pedicle division ocurred predominantly in the second operation and the median time to complete reconstruction was 6 months. There were low complication rates. Conclusions: the PMFF is safe and effective to treat nose NMSC, even in cases of high complexity. Since the treatment time can be prolonged and impact on quality of life, it is essential to emphasize and discuss this aspect with the patients before surgery.
Reference27 articles.
1. The Paramedian Forehead Flap for Nasal Reconstruction From Antiquity to Present;Shokri T;J Craniofac Surg,2019
2. The Source Book of Plastic Surgery.;McDowell F,1977
3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018
4. Prevalence and costs of skin cancer treatment in the U S., 2002-2006 and 2007-2011;Guy Jr GP;Am J Prev Med,2015
5. Cancer statistics, 2019;Siegel RL;CA Cancer J Clin,2019